Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03476798
Title Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma

endometrial carcinoma

cervix carcinoma


Bevacizumab + Rucaparib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73117 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from for the field